Searched over 200M research papers
10 papers analyzed
These studies suggest that respiratory distress symptoms can be managed through various interventions including clinical treatments, non-pharmacological approaches, and early recognition, but long-term complications and the need for further research remain significant challenges.
20 papers analyzed
Lung cancer patients often experience a cluster of respiratory distress symptoms, primarily breathlessness, cough, and fatigue. These symptoms are interrelated and significantly impact patients' daily lives. Recent studies have focused on non-pharmacological interventions to manage this symptom cluster effectively. One such intervention, the Respiratory Distress Symptom Intervention (RDSI), has shown promising results. In a randomized controlled trial, patients receiving RDSI reported significant improvements in breathlessness and cough compared to those receiving standard care. Another feasibility trial confirmed the potential of non-pharmacological interventions in managing these symptoms, suggesting the need for larger, fully powered trials to validate these findings.
Qualitative research has provided deeper insights into the experiences of lung cancer patients with respiratory distress symptoms. Longitudinal interviews with patients and caregivers revealed that these symptoms are central to the patients' experiences and significantly affect their quality of life. The study highlighted the importance of understanding symptom clusters to improve symptom management and patient outcomes.
Acute Respiratory Distress Syndrome (ARDS) is a severe condition characterized by acute onset of respiratory failure, hypoxemia, and loss of lung compliance. It can result from various triggers, including pneumonia, sepsis, and trauma. ARDS presents with symptoms such as tachypnea, cyanosis, and refractory hypoxemia, and requires intensive management strategies . Key management principles include supportive therapies like positive end-expiratory pressure (PEEP) and lung-protective ventilation to improve oxygenation and prevent further lung injury .
ARDS is associated with significant long-term complications, including cognitive impairment, psychological issues, neuromuscular weakness, and reduced quality of life. These complications persist beyond hospitalization, necessitating ongoing healthcare utilization and support. Research emphasizes the need for developing new therapies to address these long-term effects and improve patient outcomes.
Respiratory distress is a common issue in newborns, affecting up to 7% of term infants. It can result from various conditions such as transient tachypnea, respiratory distress syndrome, pneumonia, and meconium aspiration syndrome. The risk of respiratory distress decreases with advancing gestational age, but factors like elective cesarean sections have increased its incidence. Early recognition and appropriate treatment are crucial for optimal outcomes in affected infants.
Respiratory distress symptoms, whether in lung cancer patients, adults with ARDS, or newborns, present significant clinical challenges. Effective management strategies, both pharmacological and non-pharmacological, are essential to improve patient outcomes. Continued research and larger clinical trials are necessary to validate current findings and develop new therapeutic approaches. Understanding the complex interplay of symptoms and their long-term effects remains a critical area of focus in respiratory care.
Most relevant research papers on this topic